FDA Grants Emergency Use Authorization for Nitenpyram Tablets to Treat New World Screwworm in Pets
The U.S. Food and Drug Administration has granted emergency use authorization for nitenpyram tablets to treat New World screwworm in puppies, dogs, cats, and kittens. This marks the first generic animal drug approved for screwworm treatment. The authorization is part of the government's efforts to contain and eliminate the screwworm issue, with the FDA stating that nitenpyram may be effective in treating the condition in dogs and cats, outweighing potential risks. The Trump administration is actively working to combat screwworm, which has been reported in the U.S. recently.
New World screwworm flies lay eggs in wounds or mucous membranes of mammals, with larvae emerging quickly and burrowing into the animal's flesh, leading to infection and myiasis. Nitenpyram acts rapidly, with animals needing to be at least 4 weeks old and weigh over 2 pounds to receive treatment. Pet owners should administer a second dose six hours after the first and seek veterinary assistance to remove any larvae and provide wound care. The over-the-counter tablets come in 11.4 mg and 57 mg sizes, with dosing based on the animal's weight.
In conclusion, the FDA's emergency use authorization for nitenpyram tablets offers a crucial treatment option for New World screwworm in pets, providing a rapid and effective solution to combat the condition and prevent further harm to animals.